DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ)
$0.016 0.0016 (11.1111%)
Analysed DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ) News Sources
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
02-04-2026
yahoo.com
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
26-03-2026
yahoo.com
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
14-11-2025
yahoo.com
Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office
02-10-2025
yahoo.com
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
18-09-2025
yahoo.com
Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025
17-09-2025
yahoo.com
Life Science Virtual Investor Forum Agenda Announced for September 18th
16-09-2025
yahoo.com
Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th
16-09-2025
yahoo.com
Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments
10-09-2025
yahoo.com
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
13-08-2025
yahoo.com
What is the current price of DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ)?
The current price of DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ) is $0.016.
DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ) absolute price change since previous trading day?
The absolute price change of DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ) since the previous trading day is $0.0016.
DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ) percentage price change since previous trading day?
The percentage price change of DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ) since the previous trading day is 11.1111%.
What is the most recent average sentiment score for DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ)?
The most recent average sentiment score for DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ)?
The most recent sentiment for DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ) is .
SEC-8K** Filing Available For DERMATA THERAPEUTICS -CW26 (DRMAW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.